Screener
Beta Bionics BBNX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 700,000,000 shares authorized; 44,981,606 and 44,360,873 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 5 | 4 |
| Additional paid-in capital | 671,986 | 657,140 |
| Accumulated other comprehensive income (loss) | (390) | 403 |
| Accumulated deficit | (415,235) | (369,937) |
| Total stockholders’ equity | 256,366 | 287,610 |
| Total liabilities and stockholders’ equity | $292,387 | $328,743 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's total equity?
- Beta Bionics (BBNX) reported total equity of $256.37M in Q2 2026.
- How has Beta Bionics's total equity changed year-over-year?
- Beta Bionics's total equity decreased by 15.0% year-over-year, from $301.63M to $256.37M.
- What is the long-term trend for Beta Bionics's total equity?
- Over 3 years (2022 to 2025), Beta Bionics's total equity has grown at a 19.1% compound annual growth rate (CAGR), from -$170.03M to $287.61M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Beta Bionics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude